Emerald Health Therapeutics (EMHTF) Stock Price, News & Analysis

Company Overview

Emerald Health Therapeutics Inc. is a Canada-based biotechnology company specializing in the cultivation, extraction and distribution of cannabis products for both medicinal and adult-use markets. Established in 2017 and headquartered in Vancouver, British Columbia, the company leverages a network of licensed cultivation facilities and a dedicated extraction laboratory to produce high-quality cannabinoid oils, distillates and infused formulations. In addition to dried flower, Emerald Health focuses on value-added products such as vape cartridges, tinctures and capsules designed to meet evolving consumer and patient needs.

The company operates two core production sites: one in Vancouver, where climate-controlled greenhouses support small-batch, artisanal cultivation, and a larger indoor facility in Regina, Saskatchewan, optimized for high-yield, large-scale output. These facilities are designed to comply with Health Canada’s rigorous Good Production Practices (GPP), ensuring consistent product potency and safety. Emerald Health’s in-house extraction capabilities utilize closed-loop systems to isolate key cannabinoids and terpenes, enabling flexible product development across different dosage formats.

While Emerald Health’s primary markets are in Canada’s rapidly expanding medical and recreational sectors, the company has also pursued international opportunities. It holds a European Union (EU) Good Manufacturing Practice (GMP) certification for its extraction facility, positioning it to supply medical cannabis products to Germany and other EU countries where patient demand continues to grow. Strategic partnerships and distribution agreements further extend the company’s reach, supporting exports and collaborative research initiatives.

Under the leadership of Chief Executive Officer Tom Flow and a management team with deep experience in horticulture, pharmaceutical manufacturing and regulatory affairs, Emerald Health has focused on scaling its operations and broadening its product portfolio. The company’s board and leadership group draw on backgrounds in agriculture technology, clinical research and consumer packaged goods, guiding Emerald Health as it pursues innovation in cannabinoid-based therapeutics and consumer wellness products.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.04 to $0.04
• 52-Week Range: $0.02 to $0.09
• Volume: 1.05 million shs
• Average Volume: 116,962 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMHTF Stock Analysis - Frequently Asked Questions

How have EMHTF shares performed this year?

Emerald Health Therapeutics' stock was trading at $0.0405 on January 1st, 2025. Since then, EMHTF shares have increased by 0.0% and is now trading at $0.0405.

How do I buy shares of Emerald Health Therapeutics?

Shares of EMHTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Energy
• Industry: Oil & Gas Production
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EMHTF
• CIK: 1768225
• Web: www.emerald.care
• Phone: (800) 757-3536
• Fax: N/A
• Employees: 110
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A